NCT06132737View on ClinicalTrials.gov

[90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

November 7, 2023

Primary Completion Date

September 23, 2027

Study Completion Date

March 26, 2028

Conditions

CNS Lymphoma

Interventions

DRUG

[90Y]Y-PentixaTher

\[90Y\]Y-PTT i.v. injection

Trial Locations (2)

81675

RECRUITING

University Hospital Rechts der Isar, Munich

Unknown

RECRUITING

University Hospital Essen, Essen

Sponsors

Lead Sponsor

Pentixapharm AG

All Listed Sponsors

lead

Pentixapharm AG

INDUSTRY

NCT06132737 - [90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients | Biotech Hunter | Biotech Hunter